261 related articles for article (PubMed ID: 1336986)
1. Comparison of prothrombin fragment 1 + 2 with thrombin-antithrombin III complex in plasma of patients with disseminated intravascular coagulation.
Takahashi H; Wada K; Niwano H; Shibata A
Blood Coagul Fibrinolysis; 1992 Dec; 3(6):813-8. PubMed ID: 1336986
[TBL] [Abstract][Full Text] [Related]
2. Coagulopathy in disseminated intravascular coagulation due to abdominal sepsis: determination of prothrombin fragment 1 + 2 and other markers.
Okamoto K; Takaki A; Takeda S; Katoh H; Ohsato K
Haemostasis; 1992; 22(1):17-24. PubMed ID: 1387863
[TBL] [Abstract][Full Text] [Related]
3. Significant correlations between tissue factor and thrombin markers in trauma and septic patients with disseminated intravascular coagulation.
Gando S; Nanzaki S; Sasaki S; Kemmotsu O
Thromb Haemost; 1998 Jun; 79(6):1111-5. PubMed ID: 9657433
[TBL] [Abstract][Full Text] [Related]
4. High F1.2 fragment of prothrombin, thrombin-antithrombin III complex (TAT) and soluble fibrin plasma levels demonstrate hypercoagulability induced during loco-regional thrombolytic therapy with rt-PA.
Garcia-Avello A; Garcia-Frade LJ; Gandarias C; Ocaña J; Cancelas JA; Lasso M
Thromb Res; 1994 Jan; 73(2):109-15. PubMed ID: 8171409
[TBL] [Abstract][Full Text] [Related]
5. Thrombin production, inactivation and expression during open heart surgery measured by assays for activation fragments including a new ELISA for prothrombin fragment F1 + 2.
Boisclair MD; Lane DA; Philippou H; Sheikh S; Hunt B
Thromb Haemost; 1993 Aug; 70(2):253-8. PubMed ID: 8236130
[TBL] [Abstract][Full Text] [Related]
6. Determination of plasma soluble fibrin using a new ELISA method in patients with disseminated intravascular coagulation.
Okajima K; Uchiba M; Murakami K; Okabe H; Takatsuki K
Am J Hematol; 1996 Mar; 51(3):186-91. PubMed ID: 8619398
[TBL] [Abstract][Full Text] [Related]
7. Disseminated intravascular coagulation in liver cirrhosis: fact or fiction?
Ben-Ari Z; Osman E; Hutton RA; Burroughs AK
Am J Gastroenterol; 1999 Oct; 94(10):2977-82. PubMed ID: 10520855
[TBL] [Abstract][Full Text] [Related]
8. Preeclampsia as chronic disseminated intravascular coagulation. Study of two parameters: thrombin-antithrombin III complex and D-dimers.
Kobayashi T; Terao T
Gynecol Obstet Invest; 1987; 24(3):170-8. PubMed ID: 3319818
[TBL] [Abstract][Full Text] [Related]
9. [D-dimer, thrombin-antithrombin III-complex (TAT) and prothrombin fragment 1+2 (PTF). Parameters for monitoring therapy with low molecular-weight heparin in coagulation disorders].
Hofmann M; Rest A; Hafner G; Tanner B; Brockerhoff P; Weilemann LS
Anaesthesist; 1997 Aug; 46(8):689-96. PubMed ID: 9382207
[TBL] [Abstract][Full Text] [Related]
10. Prothrombin fragments F1+2, thrombin-antithrombin III complexes, fibrin monomers and fibrinogen in patients with coronary atherosclerosis.
Giannitsis E; Siemens HJ; Mitusch R; Tettenborn I; Wiegand U; Schmücker G; Sheikhzadeh A; Stierle U
Int J Cardiol; 1999 Mar; 68(3):269-74. PubMed ID: 10213277
[TBL] [Abstract][Full Text] [Related]
11. [Advancement in the diagnosis of disseminated intravascular coagulation for the surgeon].
Ohsato K; Okamoto K
Nihon Rinsho; 1993 Jan; 51(1):50-5. PubMed ID: 8381885
[TBL] [Abstract][Full Text] [Related]
12. [New useful parameters or makers in diagnosis and condition. Analysis of disseminated intravascular coagulation--mainly molecular markers].
Koike K; Fujimaki M
Nihon Rinsho; 1993 Jan; 51(1):37-42. PubMed ID: 8433526
[TBL] [Abstract][Full Text] [Related]
13. Hemostatic molecular markers before the onset of disseminated intravascular coagulation.
Wada H; Sakuragawa N; Mori Y; Takagi M; Nakasaki T; Shimura M; Hiyoyama K; Nisikawa M; Gabazza EC; Deguchi K; Kazama M; Shiku H
Am J Hematol; 1999 Apr; 60(4):273-8. PubMed ID: 10203100
[TBL] [Abstract][Full Text] [Related]
14. Prothrombin fragment 1.2 and modified antithrombin as predictors of disseminated intravascular coagulation and thrombotic risk in thermal injury.
Kowal-Vern A; Walenga JM; Hoppensteadt D; Gamelli RL
J Burn Care Res; 2013; 34(4):459-64. PubMed ID: 23202877
[TBL] [Abstract][Full Text] [Related]
15. Increased ratio of soluble fibrin formation/thrombin generation in patients with DIC.
Kushimoto S; Wada H; Kawasugi K; Okamoto K; Uchiyama T; Seki Y; Hatada T; Imai H; Nobori T;
Clin Appl Thromb Hemost; 2012 Nov; 18(6):628-32. PubMed ID: 22751910
[TBL] [Abstract][Full Text] [Related]
16. Do coagulation screening tests detect increased generation of thrombin and plasmin in sick newborn infants?
Schmidt B; Vegh P; Johnston M; Andrew M; Weitz J
Thromb Haemost; 1993 May; 69(5):418-21. PubMed ID: 8322263
[TBL] [Abstract][Full Text] [Related]
17. Prothrombin fragment F1+2 and thrombin-antithrombin III complex (TAT) plasma levels in patients with gynecological cancer.
Gadducci A; Marrai R; Baicchi U; Gagetti O; Facchini V; Genazzani AR
Gynecol Oncol; 1996 May; 61(2):215-7. PubMed ID: 8626135
[TBL] [Abstract][Full Text] [Related]
18. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.
Herren T; Straub PW; Haeberli A
Thromb Haemost; 1994 Jan; 71(1):49-53. PubMed ID: 8165646
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of pre-disseminated intravascular coagulation stage with hemostatic molecular markers. The Mie DIC Study Group.
Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Mori Y; Deguchi K; Shiku H
Pol J Pharmacol; 1996; 48(2):225-8. PubMed ID: 9112656
[TBL] [Abstract][Full Text] [Related]
20. Hemostatic study before onset of disseminated intravascular coagulation.
Wada H; Minamikawa K; Wakita Y; Nakase T; Kaneko T; Ohiwa M; Tamaki S; Deguchi A; Mori Y; Deguchi K
Am J Hematol; 1993 Jul; 43(3):190-4. PubMed ID: 8352234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
